News - Page 4 of 6 - Bách Quang

VSY Biotechnology GmbH Achieved Strong Growth in Q1 2023

VSY Biotechnology GmbH is moving towards achieving its growth targets with incremental steps. The company’s General Manager, Andreas Kühnel, evaluated the impressive Q1 2023 results of the company in the following statement: “Our net sales in the first quarter of 2023 increased by 81% compared to the same period of last year. Back in 2022, […]

Seize underutilized opportunity to treat glaucoma during vitrectomy

FDA approves twice-daily dosing option for presbyopia eye drop treatment

Asia-Pacific Eye 100: 100 Most Influential Ophthalmologists 2022

Dry eye disease alters how the eye’s cornea heals itself after injury

Cataract surgery in infancy increases glaucoma risk

Maintaining Transparency: Study to Focus on Causes of Cataracts

[20-24/10] ZANZCO’s 54th Annual Scientific Congress

[28/6-01/7/2023] 10th World Glaucoma Congress®

[8-10/2023] The 35th APACRS annual meeting

VSY Biotechnology Shares Visions for the Next 5 Years in Ophthalmic Market